Article: SUVEN LIFE SCIENCES TO PRESENT PRE-CLINICAL DATA OF PROMISING LEAD COMPOUNDS

Report from the India Press Release brought to you by the Hindustan Times

MUMBAI, India, Aug 16 -- The Bombay Stock Exchange Limited (BSE) made the following corporate announcement:

Suven Life Sciences Ltd., has announced that the Company will be presenting the Pre-clinical data of their promising lead compounds, 5-HT 6 antagonists, highly selective small molecule drug candidates, being developed for the treatment of Mild Cognitive impairment (MCI) associated with Alzheimer's disease or Schizophrenia, Parkinson and Obesity diseases with significant unmet medical need and for which current treatment options are insufficient.

"We are encouraged by the results of these preclinical studies ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!